SCHEMBL2861553

SCHEMBL2861553

COc1cc2c(cc1C#N)c(-c1ccc3ccccc3c1)nn2C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAC1 P63000 2/20 0.37
IMPDH2 P12268 1/20 0.36
IMPDH1 P20839 1/20 0.36
AR P10275 3/20 0.36
PGR P06401 2/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KDR P35968 2/20 0.35
CDK4 P11802 1/20 0.35
CCNA2 P20248 1/20 0.35
CCND1 P24385 1/20 0.35
CDK2 P24941 1/20 0.35
CCND3 P30281 1/20 0.35
PRKDC P78527 2/20 0.35
PGGT1B P53609 1/20 0.35
SRC P12931 4/20 0.34
RIPK2 O43353 1/20 0.34
PIK3CD O00329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864530 0.82 PGK1 (0.38) IMPDH2IMPDH1ARPRKDCPIK3CD
SCHEMBL2855952 0.80 IMPDH2 (0.39) IMPDH2IMPDH1ARPGRPRKDC
SCHEMBL4137412 0.74 ADORA2A (0.39) ADORA2AADORA1KDRPRKDCSRC
SCHEMBL2856284 0.72 SRC (0.35) ADORA2AADORA1KDRPRKDCSRC
SCHEMBL2861359 0.72 SRC (0.40) ADORA2AADORA1KDRPRKDCSRC
SCHEMBL4146205 0.72 ADORA2A (0.40) ADORA2AADORA1KDRPRKDCPGGT1B
SCHEMBL4159884 0.71 PIK3CD (0.38) ADORA2AADORA1KDRPRKDCSRC
SCHEMBL2858897 0.70 SRC (0.44) ADORA2AADORA1KDRPRKDCSRC
SCHEMBL2864250 0.69 KDM4E (0.38) ADORA2AALDH1A1KDM4EHTTRXFP1
SCHEMBL2858902 0.69 ADORA2A (0.38) ADORA2AADORA1ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 RAC1 2340/4885IMPDH2 2275/4885IMPDH1 1585/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 RAC1 3745/4885IMPDH2 1786/4885IMPDH1 1112/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 RAC1 2340/4885IMPDH2 2275/4885IMPDH1 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.